Condition (MeSH)
Filariasis
ClinicalTrials.gov lists 88 trials for Filariasis or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 14.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
23 of the 88 trials are tagged with Filariasis itself; the rest are tagged with a narrower condition beneath it.
When did Filariasis trials start? (25)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 10
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 4 |
| 2024 | 5 |
| 2023 | 1 |
| 2022 | 3 |
| 2021 | 10 |
| 2020 | 2 |
| 2019 | 3 |
| 2018 | 8 |
| 2017 | 8 |
Showing 10 of 25 earlier years.
No forecast is made for this condition: it averages 3.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Filariasis trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 18 |
| Phase 2/3 | 2 |
| Phase 3 | 14 |
| Phase 4 | 10 |
| Not applicable | 14 |
| Observational | 22 |
How many Filariasis trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Completed | 64 |
| Terminated | 4 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Filariasis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 14 |
| Programme National de Lutte contre l'Onchocercose, Republic of the Congo | 3 |
Which drugs are being tested for Filariasis? (5)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Ivermectin | 21 |
| Albendazole | 16 |
| Diethylcarbamazine | 11 |
| Moxidectin | 9 |
| Emodepside | 4 |
Interventions as named in the registry (10)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Doxycline | 6 |
| 1% Azithromycin | 3 |
| 2 drug dose - DA | 3 |
| 3 drug dose - IDA | 3 |
| Ivermectin + Diethylcarbamazine + Albendazole | 2 |
Showing 5 of 10 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Filariasis trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| moderate to severe malaria | 14 | 1 |
| Complicated malaria or malaria | 10 | 1 |
| Pneumonia | 6 | 1 |
| Cardiac Failure | 4 | 1 |
| Enteritis | 4 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Filariasis? (24)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania. | PLoS neglected tropical diseases | 2018 | Yes |
| Helminth infection alters IgE responses to allergens structurally related to parasite proteins. | Journal of immunology (Baltimore, Md. : 1950) | 2015 | Yes |
| Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India. | PLoS neglected tropical diseases | 2015 | Yes |
| Randomised controlled clinical trial of increased dose and frequency of albendazole and ivermectin on Wuchereria bancrofti microfilarial clearance in northern Malawi. | Transactions of the Royal Society of Tropical Medicine and Hygiene | 2015 | Yes |
| Enhanced efficacy of sequential administration of Albendazole for the clearance of Wuchereria bancrofti infection: Double blind RCT. | Tropical biomedicine | 2015 | Yes |
Showing 5 of 24 publications.
Prevalence (6)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Filariasis | Point prevalence | >1 / 1000 | Specific population | Not stated | Unspecified |
| Filariasis | Point prevalence | Unknown | Europe | Not stated | Unspecified |
| Filariasis | Point prevalence | >1 / 1000 | Specific population | Not stated | Exact |
| Filariasis | Point prevalence | >1 / 1000 | Specific population | Not stated | Exact |
| Filariasis | Point prevalence | Unknown | Europe | Not stated | Exact |
Showing 5 of 6 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Filariasis | 2034 | Exact | Orphadata Science knowledge files, Product 1 |
| Filariasis | 2034 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Sub-conditions in MeSH (5)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.